# GREAT version 3.0.0	Species assembly: hg19	"Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included"											# Ontology	 Term Name 	 Binom Rank 	 Binom Raw P-Value 	  Binom FDR Q-Val  	 Binom Fold Enrichment 	 Binom Observed Region Hits 	 Binom Region Set Coverage 	 Hyper Rank 	  Hyper FDR Q-Val  	 Hyper Fold Enrichment 	 Hyper Observed Gene Hits 	 Hyper Total Genes 	 Hyper Gene Set CoverageGO Biological Process	negative regulation of chondrocyte differentiation	1	6.76E-08	0.00070544	5.193209	17	0.017	345	0.008040392	5.794444	6	13	0.004175365MSigDB Perturbation	Transcription factors expressed in progenitors of exocrine pancreatic cells.	1	1.54E-08	5.176E-05	5.766276	17	0.017	101	0.002739703	6.847979	6	11	0.004175365GO Molecular Function	RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription	2	9.62E-08	0.000177336	2.558149	41	0.041	3	8.62553E-06	3.902114	23	74	0.01600557GO Biological Process	endocrine system development	2	3.04E-07	0.001587983	2.193153	51	0.051	53	1.00E-08	3.432906	35	128	0.0243563Mouse Phenotype	abnormal xiphoid process morphology	2	4.35E-07	0.001723333	2.776904	32	0.032	173	0.00045179	3.404645	16	59	0.01113431MGI Expression: Detected	TS16_future spinal cord	2	1.61E-07	0.000753633	2.220286	52	0.052	134	5.09E-11	3.923321	35	112	0.0243563MSigDB Perturbation	Genes within amplicon 17q21-q25 identified in a copy number alterations study of 191 breast tumor samples.	2	1.88E-07	0.000316914	2.887588	32	0.032	284	0.049395365	1.549464	39	316	0.02713987GO Molecular Function	RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription	3	2.49E-07	0.000306211	2.465065	41	0.041	4	4.34348E-05	3.564894	23	81	0.01600557MSigDB Perturbation	Genes up-regulated in pancreatic cancer cells grown in orthotopic xenograft tumors compared to those grown in vitro.	3	2.63E-07	0.000295366	5.796025	14	0.014	193	0.020479195	3.994654	7	22	0.00487126GO Molecular Function	RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity	4	7.98E-07	0.000735778	2.223702	46	0.046	2	1.14973E-05	3.380092	28	104	0.01948504MSigDB Immunologic Signatures	Genes down-regulated in comparison of B cells from LAIV influenza vaccinee at day 7 post-vaccination versus those from TIV influenza vaccinee at day 7 post-vaccination.	4	8.17899E-05	0.039054692	2.047416	35	0.035	11	0.048861099	1.961661	30	192	0.02087683GO Molecular Function	RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity	5	4.15566E-06	0.003065213	2.373794	35	0.035	16	0.005794622	2.759259	20	91	0.01391788Mouse Phenotype	abnormal heart tube morphology	7	2.63987E-06	0.002986067	2.32444	38	0.038	117	4.57884E-05	3.211649	22	86	0.01530967MGI Expression: Detected	TS26_islets of Langerhans	8	3.89E-07	0.000454019	5.197384	15	0.015	1013	0.005262171	6.277314	5	10	0.003479471GO Molecular Function	enhancer sequence-specific DNA binding	9	8.673E-05	0.035540043	2.993891	17	0.017	30	0.035789852	3.896264	9	29	0.006263048GO Biological Process	heart valve morphogenesis	10	1.01985E-06	0.00106472	3.698232	20	0.02	250	0.000995316	4.649862	10	27	0.006958942Human Phenotype	Acute lymphatic leukemia	11	5.03964E-05	0.028157821	6.35689	8	0.008	49	0.007318365	8.967591	5	7	0.003479471MSigDB Perturbation	Genes up-regulated in prostate cancer samples.	11	3.19976E-05	0.009785457	2.393132	28	0.028	205	0.023799151	2.28266	16	88	0.01113431GO Biological Process	heart valve development	12	1.37109E-06	0.001192852	3.48886	21	0.021	209	0.000354657	4.7621	11	29	0.007654836Mouse Phenotype	abnormal stapes morphology	12	4.35462E-06	0.002873321	3.233666	21	0.021	525	0.024852641	3.138657	9	36	0.006263048MSigDB Predicted Promoter Motifs	Motif YTTCCNNNGGAMR (no known TF)	12	0.000216387	0.011089824	2.767183	17	0.017	177	0.00023463	3.400212	13	48	0.009046625GO Biological Process	Sertoli cell differentiation	13	1.84592E-06	0.001482413	4.573952	15	0.015	255	0.001377654	5.579835	8	18	0.005567154Mouse Phenotype	vertebral fusion	14	5.01312E-06	0.00283528	2.319698	36	0.036	177	0.000496369	2.673671	23	108	0.01600557GO Biological Process	liver development	15	2.08763E-06	0.001452988	2.451332	35	0.035	231	0.000673039	2.853324	20	88	0.01391788Human Phenotype	Abnormality of the tibia	15	7.0333E-05	0.028817787	2.832866	19	0.019	90	0.022865169	3.288117	11	42	0.007654836Mouse Phenotype	abnormal conotruncus morphology	16	5.83663E-06	0.002888401	3.170868	21	0.021	387	0.010368862	3.644892	9	31	0.006263048MGI Expression: Detected	TS19_axial skeleton	16	7.57E-07	0.000441997	3.177849	25	0.025	663	0.000190917	3.487397	15	54	0.01043841GO Biological Process	Sertoli cell development	17	2.38329E-06	0.001463618	5.65327	12	0.012	398	0.014975608	6.277314	5	10	0.003479471MSigDB Perturbation	"Genes consistently overexpressed with age, based on meta-analysis of microarray data."	18	6.5677E-05	0.012274298	3.352515	15	0.015	144	0.010209186	2.863336	13	57	0.009046625Mouse Phenotype	bowed fibula	19	6.73477E-06	0.002806626	5.094631	12	0.012	346	0.006991287	6.974793	5	9	0.003479471MGI Expression: Detected	TS16_future forebrain	19	1.03958E-06	0.000510871	2.179745	47	0.047	146	1.18E-10	4.09947	32	98	0.02226862MSigDB Perturbation	Genes with intermediate-CpG-density promoters (ICP) bearing the bivalent tri-methylation marks at H3K4 (H3K4me3) and H3K27 (H3K27me3) in MEF cells (embryonic fibroblasts).	19	0.000083708	0.014820722	2.499926	23	0.023	15	2.45E-07	5.616544	17	38	0.0118302GO Biological Process	eye morphogenesis	20	3.13933E-06	0.001638728	2.071238	48	0.048	70	6.61E-08	3.258453	34	131	0.0236604GO Biological Process	hepaticobiliary system development	23	3.72168E-06	0.00168932	2.386154	35	0.035	245	0.00090251	2.789917	20	90	0.01391788Mouse Phenotype	conotruncal ridge hypoplasia	23	1.2361E-05	0.004255419	4.78891	12	0.012	454	0.01705893	5.706649	5	11	0.003479471MSigDB Perturbation	"Genes down-regulated in MCF10A cells (breast cancer) grown at low (mesenchymal phenotype) compared to those grown at high (epithelial, basal-like phenotype) confluency."	23	0.000143176	0.020941032	2.0355	33	0.033	254	0.03645633	1.891793	22	146	0.01530967MSigDB Perturbation	Genes up-regulated in hepatocellular carcinoma (HCC) cells with hepatic stem cell properties.	24	0.000144899	0.020310024	2.675775	19	0.019	267	0.042611901	2.671197	10	47	0.006958942GO Biological Process	endocrine pancreas development	25	4.30577E-06	0.001798091	2.803838	26	0.026	364	0.010282084	3.074603	12	49	0.008350731Mouse Phenotype	abnormal heart valve morphology	25	1.72219E-05	0.005454527	2.065226	41	0.041	256	0.002312261	2.335745	24	129	0.01670146Disease Ontology	bone development disease	25	0.000221377	0.019791122	2.585736	19	0.019	83	0.040910948	2.64308	12	57	0.008350731Mouse Phenotype	abnormal ilium morphology	27	1.76572E-05	0.005178126	5.043687	11	0.011	645	0.044748289	5.579835	4	9	0.002783577MSigDB Predicted Promoter Motifs	"Motif NTCAAGKTCAAGKTCANN matches NR6A1: nuclear receptor subfamily 6, group A, member 1"	27	0.000843643	0.019216311	2.075184	24	0.024	173	0.000196384	2.884171	17	74	0.0118302GO Biological Process	positive regulation of male gonad development	28	5.28458E-06	0.001970394	5.220905	12	0.012	393	0.014013835	8.369752	4	6	0.002783577GO Biological Process	limb bud formation	29	5.6504E-06	0.002034143	3.735661	17	0.017	294	0.002920936	6.847979	6	11	0.004175365MSigDB Perturbation	"Breast cancer compendium: 100 transcription regulators showing most correlated expression with the 9 'embryonic stem cell' transcription factors that are preferentially and coordinately overexpressed in the high-grade, ER-negative breast cancer tumors."	29	0.000239549	0.027787649	2.085276	29	0.029	181	0.017894203	2.237458	18	101	0.0125261GO Biological Process	regulation of skeletal muscle tissue development	30	6.78333E-06	0.002360598	2.670016	27	0.027	153	4.7848E-05	3.880521	17	55	0.0118302GO Biological Process	renal tubule morphogenesis	31	6.93713E-06	0.002336247	3.370095	19	0.019	168	7.66114E-05	5.524036	11	25	0.007654836MSigDB Perturbation	Cluster 4: genes down-regulated in lung tissue samples from mice with tumor-bearing genotypes (activated KRAS [GeneID=3845] alone or together with inactivated PTEN [GeneID=5728]).	31	0.000299273	0.032475926	2.056465	29	0.029	109	0.003374848	2.38105	22	116	0.01530967GO Biological Process	nephron tubule morphogenesis	32	7.19572E-06	0.002347604	3.665696	17	0.017	232	0.000689453	5.380555	9	21	0.006263048GO Biological Process	regulation of striated muscle tissue development	34	9.4743E-06	0.002909167	2.076964	43	0.043	57	1.40E-08	3.706604	31	105	0.02157272MGI Expression: Detected	TS20_urogenital system	34	1.64038E-06	0.000450477	6.516146	11	0.011	1409	0.029564328	7.532777	3	5	0.002087683MGI Expression: Detected	TS19_branchial arch mesenchyme	35	1.66963E-06	0.000445408	4.612316	15	0.015	497	1.10538E-05	8.369752	8	12	0.005567154Mouse Phenotype	abnormal neural crest cell morphology	36	2.84381E-05	0.0062548	2.843628	21	0.021	255	0.002275111	3.836136	11	36	0.007654836GO Biological Process	regulation of muscle cell differentiation	37	1.06187E-05	0.002996181	2.109908	41	0.041	126	1.18255E-05	3.026562	27	112	0.01878914GO Biological Process	renal tubule development	38	1.06694E-05	0.002931264	2.866753	23	0.023	122	7.00637E-06	4.955774	15	38	0.01043841MGI Expression: Detected	TS22_intervertebral disc	39	1.92772E-06	0.000461516	4.058036	17	0.017	732	0.000429216	5.579835	8	18	0.005567154GO Biological Process	regulation of muscle organ development	40	1.17406E-05	0.003064291	2.058091	43	0.043	62	2.18E-08	3.637322	31	107	0.02157272Mouse Phenotype	fused joints	40	3.76083E-05	0.007444557	2.056797	38	0.038	171	0.00038136	2.593931	25	121	0.01739736MGI Expression: Detected	TS20_cervical vertebral cartilage condensation	40	1.97843E-06	0.000461815	5.758413	12	0.012	1337	0.024178905	4.483796	5	14	0.003479471MSigDB Perturbation	"Oligodendrocyte core differentiation genes: up-regulated in Oli-neo cells (oligodendroglial precursor) at 10 h after treatment with PD174265, dexamethasone or isotretinoin [PubChemID=4709, 5743, 5282379]."	40	0.000568517	0.047812263	2.626894	16	0.016	74	0.000349342	4.080254	13	40	0.009046625Mouse Phenotype	abnormal neural crest morphology	43	3.8409E-05	0.00707261	2.783718	21	0.021	293	0.003419338	3.634234	11	38	0.007654836MSigDB Perturbation	Genes down-regulated in 3T3-L1 cells (adipocyte) by insulin [GeneID=3630] but displayed blunted response to insulin the insulin resistant cells.	43	0.000598001	0.046783125	4.389735	8	0.008	226	0.030239577	4.184876	6	18	0.004175365GO Biological Process	nephron tubule development	44	1.54562E-05	0.003667335	2.878642	22	0.022	133	2.17247E-05	4.882355	14	36	0.009742519MGI Expression: Detected	TS16_trunk mesenchyme derived from neural crest	44	2.04855E-06	0.000434712	5.738623	12	0.012	780	0.000698442	8.967591	5	7	0.003479471Mouse Phenotype	abnormal pancreas development	48	4.98234E-05	0.008218792	2.590077	23	0.023	446	0.016363438	3.138657	10	40	0.006958942MGI Expression: Detected	TS24_vestibulocochlear VIII ganglion cochlear component	48	2.30763E-06	0.000448882	7.094592	10	0.01	984	0.004785924	12.55463	3	3	0.002087683Mouse Phenotype	abnormal testis development	49	5.22813E-05	0.008448228	2.805743	20	0.02	311	0.004166765	3.541049	11	39	0.007654836MSigDB Predicted Promoter Motifs	"Motif RGTTAMWNATT matches TCF1: transcription factor 1, hepatic; LF-B1, hepatic nuclear factor (HNF1), albumin proximal factor"	49	0.002985558	0.037471799	2.109771	18	0.018	271	0.00831783	2.298735	13	71	0.009046625Mouse Phenotype	abnormal deltoid tuberosity morphology	52	6.40948E-05	0.009759669	3.071095	17	0.017	387	0.010368862	3.644892	9	31	0.006263048Mouse Phenotype	abnormal testis cord formation	53	6.75753E-05	0.010095487	4.00753	12	0.012	628	0.043653245	4.483796	5	14	0.003479471Mouse Phenotype	abnormal trachea morphology	54	7.09678E-05	0.010405985	2.208861	30	0.03	127	7.56157E-05	3.587036	18	63	0.0125261Mouse Phenotype	abnormal conotruncal ridge morphology	55	7.10457E-05	0.010228003	2.930683	18	0.018	441	0.016033602	3.71989	8	27	0.005567154MGI Expression: Detected	TS20_inner ear epithelium	55	3.12664E-06	0.00053079	4.678191	14	0.014	1274	0.017447401	4.828703	5	13	0.003479471MGI Expression: Detected	TS19_skeleton	56	3.33029E-06	0.000555266	2.845457	26	0.026	683	0.000267583	3.239904	16	62	0.01113431Mouse Phenotype	abnormal atrioventricular valve morphology	57	8.4219E-05	0.011699051	2.259199	28	0.028	237	0.001534106	2.92368	17	73	0.0118302MGI Expression: Detected	TS20_axial skeleton cervical region	62	3.73219E-06	0.000562056	4.962522	13	0.013	1045	0.006024597	5.021851	6	15	0.004175365MGI Expression: Detected	TS16_diencephalon	64	3.81051E-06	0.000555917	2.642869	29	0.029	489	9.98733E-06	3.952383	17	54	0.0118302Mouse Phenotype	abnormal ischium morphology	66	0.000123153	0.01477464	3.755167	12	0.012	454	0.01705893	5.706649	5	11	0.003479471MGI Expression: Detected	TS13_paraxial mesenchyme	77	7.2538E-06	0.000879593	2.005297	48	0.048	398	1.36415E-06	2.942491	30	128	0.02087683MGI Expression: Detected	TS19_leg	78	7.55181E-06	0.000903991	3.49015	18	0.018	925	0.002937163	4.882355	7	18	0.00487126MGI Expression: Detected	TS26_lower respiratory tract	81	8.59364E-06	0.000990603	4.970146	12	0.012	1443	0.031422693	4.184876	5	15	0.003479471MGI Expression: Detected	TS20_notochord	87	1.07869E-05	0.001157674	4.185313	14	0.014	1170	0.011582365	4.431045	6	17	0.004175365MGI Expression: Detected	TS23_gallbladder	89	1.14564E-05	0.001201892	9.583943	7	0.007	1409	0.029564328	7.532777	3	5	0.002087683MGI Expression: Detected	TS17_sclerotome	92	1.23834E-05	0.001256775	3.890081	15	0.015	1436	0.031400266	3.587036	6	21	0.004175365